NEW YORK, NY / ACCESSWIRE / August 18, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Coinbase Global, Inc. (NASDAQ:COIN)
CONTACT JAKUBOWITZ ABOUT COIN:
https://claimyourloss.com/securities/coinbase-global-inc-loss-submission-form/?id=18679&from=1
This lawsuit is on behalf of all persons and entities that purchased or otherwise acquired Coinbase Class A common stock pursuant and/or traceable to the Company's registration statement and prospectus for the resale of up to 114,850,769 shares of its Class A common stock, whereby Coinbase began trading as a public company on or around April 14, 2021.
Lead Plaintiff Deadline: September 20, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company required a sizeable cash injection; (2) the Company's platform was susceptible to service-level disruptions, which were increasingly likely to occur as the Company scaled its services to a larger user base; and (3) as a result of the foregoing Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Ardelyx, Inc. (NASDAQ:ARDX)
CONTACT JAKUBOWITZ ABOUT ARDX:
https://claimyourloss.com/securities/ardelyx-inc-loss-submission-form/?id=18679&from=1
Class Period: August 6, 2020 - July 19, 2021
Lead Plaintiff Deadline: September 28, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: 1) the Company overstated the likelihood that tenapanor would be approved by the Food and Drug Administration ("FDA"); and 2) Defendants possessed, were in control over, and as a result, knew that the data submitted to support the New Drug Application was insufficient in that it showed a lack of clinical relevance of the drug's treatment effect, making it foreseeably likely that the FDA would not approve the drug.
Yalla Group Limited (NYSE:YALA)
CONTACT JAKUBOWITZ ABOUT YALA:
https://claimyourloss.com/securities/yalla-group-limited-loss-submission-form/?id=18679&from=1
Class Period: September 30, 2020 - August 9, 2021
Lead Plaintiff Deadline: October 12, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company overstated its user metrics and revenue and, as a result, the Company's public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com:
https://www.accesswire.com/660377/Lawsuits-Filed-Against-COIN-ARDX-and-YALA--Jakubowitz-Law-Pursues-Shareholders-Claims
